Pharmacogenetics of Response to Sitagliptin (PRS)

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2030

Study Completion Date

August 31, 2031

Conditions
Diabetes
Interventions
PROCEDURE

Oral Glucose Tolerance Test

Three hour glucose tolerance test

Trial Locations (1)

17602

University of Maryland Amish Research Clinic, Lancaster

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER